Covid-19 is still circulating, though it's weaker now. Experts say it’s not a major threat but advise maintaining strong ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Here, the authors show that the complement system enhances the antibody-mediated neutralisation of SARS-CoV-2 via increased inhibition of virus-host interactions. Here the authors characterise the ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

Scientists found that it can bind to human ACE2 receptors, similar to SARS-CoV-2 (the virus behind COVID-19). This suggests it has the potential for animal-to-human transmission. Experts note that ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

The discovery raises concerns about the virus's similarity to SARS-CoV-2 and its potential implications.

What causes long Covid? Scientists don't fully understand why some develop disabling chronic complications after recovering ...